GFI1
Zinc finger protein Gfi-1
Also known as: GFI-1, GFI1_HUMAN, GFI1A, ZNF163
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q99684
- Gene
- GFI1
- Ensembl
- ENSG00000162676
- Chromosome
- 1
- Canonical length
- 422 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors
OverviewNCBI Gene
This gene encodes a nuclear zinc finger protein that functions as a transcriptional repressor. This protein plays a role in diverse developmental contexts, including hematopoiesis and oncogenesis. It functions as part of a complex along with other cofactors to control histone modifications that lead to silencing of the target gene promoters. Mutations in this gene cause autosomal dominant severe congenital neutropenia, and also dominant nonimmune chronic idiopathic neutropenia of adults, which are heterogeneous hematopoietic disorders that cause predispositions to leukemias and infections. Multiple alternatively spliced variants, encoding the same protein, have been identified for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
422 residues, UniProt reviewed canonical sequence.
>Q99684|GFI1
1 MPRSFLVKSK KAHSYHQPRS PGPDYSLRLE NVPAPSRADS TSNAGGAKAE PRDRLSPESQ
61 LTEAPDRASA SPDSCEGSVC ERSSEFEDFW RPPSPSASPA SEKSMCPSLD EAQPFPLPFK
121 PYSWSGLAGS DLRHLVQSYR PCGALERGAG LGLFCEPAPE PGHPAALYGP KRAAGGAGAG
181 APGSCSAGAG ATAGPGLGLY GDFGSAAAGL YERPTAAAGL LYPERGHGLH ADKGAGVKVE
241 SELLCTRLLL GGGSYKCIKC SKVFSTPHGL EVHVRRSHSG TRPFACEMCG KTFGHAVSLE
301 QHKAVHSQER SFDCKICGKS FKRSSTLSTH LLIHSDTRPY PCQYCGKRFH QKSDMKKHTF
361 IHTGEKPHKC QVCGKAFSQS SNLITHSRKH TGFKPFGCDL CGKGFQRKVD LRRHRETQHG
421 LKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GFI1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.59
- Highest tissue expression
- 76 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 76 nTPM
- thymus: 44 nTPM
- pancreas: 12 nTPM
- lymph node: 9.9 nTPM
- appendix: 8.2 nTPM
- spleen: 8 nTPM
Single-cell type
- neutrophil progenitors: 83 nCPM
- paneth cells: 23 nCPM
- t-cells: 23 nCPM
- innate lymphoid cells: 22 nCPM
- nk-cells: 21 nCPM
- goblet cells: 21 nCPM
Immune cell
- gdT-cell: 3.5 nTPM
- naive CD8 T-cell: 2.9 nTPM
- memory CD8 T-cell: 1.8 nTPM
- plasmacytoid DC: 1.6 nTPM
- MAIT T-cell: 1.5 nTPM
- memory CD4 T-cell: 1.3 nTPM
Brain region
- medulla oblongata: 1.2 nTPM
- choroid plexus: 1.1 nTPM
- pons: 1 nTPM
- spinal cord: 1 nTPM
- thalamus: 0.9 nTPM
- cerebral cortex: 0.8 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GFI1.
Disease | AllUniProt
Conditions GFI1 is implicated in, by any mechanism.
- Neutropenia, severe congenital 2, autosomal dominant (SCN2) MIM:613107
- Dominant nonimmune chronic idiopathic neutropenia of adults (NI-CINA) MIM:607847
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 788 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Neutropenia, severe congenital, 2, autosomal dominant
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.56
- gnomAD pLI
- 0.25
- gnomAD missense Z
- 1.59
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to lipopolysaccharide
- DNA damage response
- negative regulation of DNA-templated transcription
- negative regulation of neuron projection development
- negative regulation of NF-kappaB transcription factor activity
- negative regulation of transcription by RNA polymerase II
- negative regulation of vitamin D biosynthetic process
- positive regulation of interleukin-6-mediated signaling pathway
- regulation of toll-like receptor signaling pathway
- regulation of transcription by RNA polymerase II
Molecular functions
- DNA-binding transcription factor activity
- DNA-binding transcription repressor activity, RNA polymerase II-specific
- enzyme-substrate adaptor activity
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
- transcription cis-regulatory region binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GFI1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GFI1 as an antibody target. Whether an autoantibody or antibody against GFI1 could matter depends on whether native GFI1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GFI1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GFI1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...